Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia

Journal of International Medical Research

Volumn 40, Issue 2, 2012, Pages 486-496

  Kim, J W ^a,b   Song, S H ^a   Jin, C H ^a   Lee, J K ^a   Lee, N W ^a,b   Lee, K W ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Progression; Viral clearance; Viral load

Indexed keywords

VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PARITY; PREDICTION; RETROSPECTIVE STUDY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRAL CLEARANCE; VIRUS LOAD; WART VIRUS;

EID: 84860453255     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000210     Document Type: Article

References (39)

1. Bosch FX, Lorincz A, Muñoz N, et al: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
2. Ambros RA, Kurman RJ: Current concepts in the relationship of human papillomavirus infection to the pathogenesis and classification of precancerous squamous lesions of the uterine cervix. Semin Diagn Pathol 1990; 7: 158-172.
3. Evander M, Edlund K, Gustafsson A, et al: Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995; 171: 1026-1030.
4. Ho GY, Bierman R, Beardsley L, et al: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.
5. Coupé VM, Bogaards JA, Meijer CJ, et al: Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening. Vaccine 2012; 30: 1813-1822.
6. Josefsson AM, Magnusson PK, Ylitalo N, et al: Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2189-2193.
7. Kjaer SK, van den Brule AJ, Paull G, et al: Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325: 572.
8. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999; 354: 20-25.
9. Sellors JW, Mahony JB, Kaczorowski J, et al: Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000; 163: 503-508.
10. Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-698.
11. Bansal N, Wright JD, Cohen CJ, et al: Natural history of established low-grade cervical intraepithelial (CIN 1) lesions. Anticancer Res 2008; 28: 1763-1766.
12. Ye J, Cheng X, Chen X, et al: Short-term type-specific HPV persistence and its predictors in an asymptomatic general female population in Zhejiang, China. Int J Gynaecol Obstet 2010; 110: 217-222.
13. Bae J, Seo SS, Park YS, et al: Natural history of persistent high-risk human papillomavirus infections in Korean women. Gynecol Oncol 2009; 115: 75-80.
14. Fukuchi E, Sawaya GF, Chirenje M, et al: Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis 2009; 36: 305-311.
15. Muñoz N, Hernandez-Suarez G, Méndez F, et al: Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer 2009; 100: 1184-1190.
16. Goodman MT, Shvetsov YB, McDuffie K, et al: Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008; 68: 8813-8824.
17. Hernández-Suárez G, Ortiz N, González M, et al: Short-term risk of cervical intraepithelial neoplasia grades 2 and 3 for women with normal cytology and human papillomavirus infection. Salud Publica Mex 2010; 52: 486-492.
18. Guo YL, You K, Qiao J, et al: Natural history of infections with high-risk HPV in Chinese women with abnormal cervical cytology findings at baseline. Int J Gynaecol Obstet 2010; 110: 137-140.
19. Song SH, Lee JK, Oh MJ, et al: Risk factors for the progression or persistence of untreated mild dysplasia of the uterine cervix. Int J Gynecol Cancer 2006; 16: 1608-1613.
20. Pretorius RG, Peterson P, Azizi F, et al: Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol 2006; 195: 1260-1265.
21. International Collaboration of Epidemiological Studies of Cervical Cancer: Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006; 119: 1108-1124.
22. Castle PE, Walker JL, Schiffman M, et al: Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer 2005; 117: 1007-1012.
23. Dalstein V, Riethmuller D, Prétet JL, et al: Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003; 106: 396-403.
24. Yokoyama M, Iwasaka T, Nagata C, et al: Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan. Cancer Lett 2003; 192: 171-179.
25. Yoshikawa H, Nagata C, Noda K, et al: Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 1999; 80: 621-624.
26. Maucort-Boulch D, Plummer M, Castle PE, et al: Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int J Cancer 2010; 126: 684-691.
27. Huang Y, Huang MN, Li N, et al: Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. Int J Gynecol Cancer 2008; 18: 755-760.
28. Solomon D, Davey D, Kurman R, et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-2119.
29. Monnier-Benoit S, Dalstein V, Riethmuller D, et al: Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol 2006; 35: 270-277.
30. Ho GY, Burk RD, Klein S, et al: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-1371.
31. Ylitalo N, Sørensen P, Josefsson AM, et al: Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2194-2198.
32. Flores R, Papenfuss M, Klimecki WT, et al: Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 2006; 118: 1187-1193.
33. Sun CA, Lai HC, Chang CC, et al: The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001; 83: 95-99.
34. Hong JH, Kim MK, Lee IH, et al: Association between serum cytokine profiles and clearance or persistence of high-risk human papillomavirus infection: a prospective study. Int J Gynecol Cancer 2010; 20: 1011-1016.
35. Song SH, Lee JK, Lee NW, et al: Interferon-γ (IFN-γ): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV). Gynecol Oncol 2008; 108: 543-548.
36. Castellsagué X, Muñoz N: Chapter 3: cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 2003: 20-28.
37. Prétet JL, Dalstein V, Monnier-Benoit S, et al: High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J Clin Virol 2004; 31: 140-147.
38. Plummer M, Schiffman M, Castle PE, et al: A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195: 1582-1589.
39. Castellsagué X: Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008; 110(3 suppl 2): S4-S7.